SynopsisThe global market for Central Venous Access Devices was valued at US$ 1756 million in the year 2024 and is projected to reach a revised size of US$ 2363 million by 2031, growing at a CAGR of 4.4% during the forecast period. Central venous access devices .....
SynopsisThe global market for Neurorehabilitation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. North American market for Neurorehabilitation is estim.....
SynopsisThe global market for Rotating Anode X-ray Tubes was valued at US$ 1638 million in the year 2024 and is projected to reach a revised size of US$ 2449 million by 2031, growing at a CAGR of 6.0% during the forecast period. An X-ray tube is a vacuum tube th.....
SynopsisThe global market for Mepivacaine Hydrochloride Injection was valued at US$ 146 million in the year 2024 and is projected to reach a revised size of US$ 194 million by 2031, growing at a CAGR of 4.0% during the forecast period. Mepivacaine is indicated f.....
SynopsisThe global market for Disposable Nitrile Surgical Gloves was valued at US$ 2160 million in the year 2024 and is projected to reach a revised size of US$ 3357 million by 2031, growing at a CAGR of 6.5% during the forecast period. Disposable nitrile surgic.....
SynopsisThe global market for Surgical Robots for the Spine was valued at US$ 234 million in the year 2024 and is projected to reach a revised size of US$ 730 million by 2031, growing at a CAGR of 17.9% during the forecast period. Spinal surgery has evolved dram.....
SynopsisThe global market for Track-etched Membrane was valued at US$ 353 million in the year 2024 and is projected to reach a revised size of US$ 528 million by 2031, growing at a CAGR of 6.0% during the forecast period. Track-etched membranes have well-defined.....
SynopsisThe global market for Rapid Influenza Diagnostic Test (RIDT) was valued at US$ 1053 million in the year 2024 and is projected to reach a revised size of US$ 2025 million by 2031, growing at a CAGR of 9.9% during the forecast period. In China, the key pla.....
SynopsisThe global market for Mitoxantrone Hydrochloride Injection was valued at US$ 205 million in the year 2024 and is projected to reach a revised size of US$ 290 million by 2031, growing at a CAGR of 5.0% during the forecast period. Mitoxantrone is an antine.....
SynopsisThe global market for Pacemakers and Cardiac Resynchronization Therapy Devices was valued at US$ 11890 million in the year 2024 and is projected to reach a revised size of US$ 14680 million by 2031, growing at a CAGR of 3.1% during the forecast period. C.....








